A detailed history of Vise Technologies, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Vise Technologies, Inc. holds 15,648 shares of ABT stock, worth $1.8 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
15,648
Previous 6,147 154.56%
Holding current value
$1.8 Million
Previous $638,000 179.62%
% of portfolio
0.23%
Previous 0.11%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.07 - $118.13 $950,765 - $1.12 Million
9,501 Added 154.56%
15,648 $1.78 Million
Q2 2024

Aug 01, 2024

BUY
$100.73 - $112.44 $238,931 - $266,707
2,372 Added 62.83%
6,147 $638,000
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $35,265 - $38,949
-322 Reduced 7.86%
3,775 $429,000
Q4 2023

Feb 07, 2024

SELL
$90.19 - $110.4 $43,381 - $53,102
-481 Reduced 10.51%
4,097 $450,000
Q3 2023

Oct 31, 2023

BUY
$95.53 - $114.62 $130,111 - $156,112
1,362 Added 42.35%
4,578 $443,000
Q2 2023

Aug 08, 2023

BUY
$100.78 - $112.29 $3,728 - $4,154
37 Added 1.16%
3,216 $350,000
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $3,971 - $4,674
41 Added 1.31%
3,179 $321,000
Q4 2022

Feb 09, 2023

SELL
$95.06 - $111.52 $28,518 - $33,456
-300 Reduced 8.73%
3,138 $344,000
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $22,254 - $25,766
230 Added 7.17%
3,438 $333,000
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $108,704 - $131,389
1,065 Added 49.7%
3,208 $349,000
Q1 2022

Jun 08, 2022

BUY
$114.02 - $139.04 $244,344 - $297,962
2,143 New
2,143 $254,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Vise Technologies, Inc. Portfolio

Follow Vise Technologies, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vise Technologies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vise Technologies, Inc. with notifications on news.